United Kingdom · Question · Written question
HL HL4492
Immunotherapy
Introduced
29 November 2021
Last action
10 December 2021 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
10 December 2021
Summary
To ask Her Majesty's Government why patients dependent on immunoglobulin are experiencing (1) treatment "holidays", (2) longer waits between treatments, and (3) smaller doses; and what steps they are taking to secure (a) a stable, and (b) a secure, supply
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
29 November 2021
Written question
To ask Her Majesty's Government why patients dependent on immunoglobulin are experiencing (1) treatment "holidays", (2) longer waits between treatments, and (3) smaller doses; and what steps they are taking to secure (a) a stable, and (b) a secure, supply
Source: Lords
10 December 2021
Answer
Clinicians are responsible for the management of patients, including dosage and dosing intervals, with the oversight and governance of sub-regional immunoglobulin assessment panels. The decision to recommend treatment holidays, extended intervals between ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-11-29/HL4492
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1383187
- uk · wq-1383187 · source updated 10 December 2021